DI-ATRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Di-atro, and when can generic versions of Di-atro launch?
Di-atro is a drug marketed by Md Pharm and is included in one NDA.
The generic ingredient in DI-ATRO is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DI-ATRO?
- What are the global sales for DI-ATRO?
- What is Average Wholesale Price for DI-ATRO?
Summary for DI-ATRO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 60 |
| DailyMed Link: | DI-ATRO at DailyMed |
US Patents and Regulatory Information for DI-ATRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Md Pharm | DI-ATRO | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 085266-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
